rd4sndk

FASB Unlikely to Suspend Mark to Market

The only important measure for transparency is the cash flow from the asset and the future discard value. There's nothing else necessary to evaluate a companies asset. Fair value accounting doesn't do neither which is why transparency claims are hollow and disengenuous. Congress should can mark to market as it provides unrealistic expectations of assets during before and after market turmoil. Pricing the value of one asset to the that of one based on proximity and type is as stupid as valuing Toyota based on Chryslers performance.

The Pfizer-Wyeth Deal: Experimenting with Taxpayer Dollars?

Its this type of blog that's driving me crazy. Do you expect Pfizer to welch on its loans or that the expected $20B in CF to not materialize? How obsurb is to restrict the banks from loaning to a bluechip company with $20B+ in cash reserves and a FCF greater than $10B. Find something else to do with your time and leave us alone with absurb fears of Pfizer failures. I for one welcome such transactions and plan to take part in the arbitrage shortfall to reap my 12% in 90 days.

There are transactions that unhealthy banks have made and I didn't hear you questioning those like Citi's planned purchase of Wachovia etc. Now there's a merger that was rightfully terminated.